Kraig Biocraft Laboratories, Inc.
KBLB
$0.09
$0.002.82%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -107.91% | -21.02% | 29.55% | -96.61% | 73.03% |
| Total Depreciation and Amortization | -41.73% | 547.37% | -71.21% | 200.00% | -1.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19,322.22% | 107.64% | -208.87% | 189.27% | -106.84% |
| Change in Net Operating Assets | -37.03% | 10.52% | -17.57% | 64.89% | -20.62% |
| Cash from Operations | -4.24% | -1.98% | 15.22% | -57.06% | 36.12% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 51.36% | -- | -- | -- | -- |
| Cash from Investing | 55.26% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 65.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,244.89% | -206.32% | -- | -- | -- |
| Cash from Financing | 48.13% | 334.96% | -- | 100.00% | 65.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.82% | 240.61% | 46.54% | -55.90% | 36.95% |